Navigation Links
Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
Date:2/26/2009

ezomib. We continue to be encouraged by the evolving data on the combination of perifosine and bortezomib in patients with multiple myeloma."

One additional multiple myeloma clinical poster was presented as follows:

Phase 1 Updated Results of Perifosine (KRX-0401) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (MM)

Perifosine in combination with Revlimid(R) + dexamethasone continues to be well tolerated, with a median progression-free survival in responding patients of 10.9 months. Median overall survival still has not been reached now at 17 months. Nine patients remain on active treatment.

KRX-0401 (perifosine) is in-licensed by Keryx from Aeterna Zentaris, Inc. (Nasdaq: AEZS; TSX: AEZ) in the United States, Canada and Mexico.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Serene(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Serene is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell surviva
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
9. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
10. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015 BiondVax ... preliminary results from its BVX-006 Phase II clinical trial ... In this trial, M-001 was injected intramuscularly to volunteers ... an administration of the 2014/15 season trivalent influenza vaccine ... safe and well tolerated and induced humoral immune responses, ...
(Date:6/29/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Russell 1000 Index, effective June 26, 2015. The Russell ... of the U.S. equity universe. It is a subset ... of the largest securities based on a combination of ... "We are pleased to be added to this important ...
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
(Date:6/30/2015)... ... 2015 , ... This Fourth of July, Peacock Alley celebrates the ... work, tenacity, perseverance, commitment to quality, honesty and love of friends and family. These ... Gabler's simple love of quilts, Peacock Alley was fully realized and grown while raising ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Curly Hair ... 14, the largest beauty event in the US, featuring products from all over the ... Keeper™ Collection. The Collection is a line of hair styling products focused entirely on ...
(Date:6/29/2015)... City, NY (PRWEB) , ... June 30, 2015 ... ... honors Melanie Richards as a 2015-2016 inductee into its VIP ... leadership in business. NAPW is the nation’s leading networking organization exclusively for professional ...
(Date:6/29/2015)... ... June 30, 2015 , ... Leaders ... one of the industry’s premier thought leadership symposiums, “Harmony 2015” hosted by Massachusetts-based ... rehabilitation managers and other management and corporate personnel representing the skilled nursing and ...
(Date:6/29/2015)... ... ... The United States Equestrian Federation (USEF) is pleased to announce a ... Occupational Therapists of the U.S. Eventing Team. KORT also provided the official onsite ... , “The USEF is pleased to welcome the Kentucky Orthopedic Rehab Team as the ...
Breaking Medicine News(10 mins):Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:National Association of Professional Women Inducts Melanie Richards, DMD, of Powdersville Pediatric Dentistry, Into its VIP Woman of the Year Circle 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 3Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2
... Practicing Clinicians Exchange (PCE) has formed a ... to provide continuing education programs to nurse practitioners ... States.The partnership capitalizes on the strengths of both ... advocacy and research in RLS, and PCE is ...
... Genoptix, Inc. (Nasdaq: GXDX ), a specialized ... Bank of America and Merrill Lynch 2009 Annual Health Care ... City on May 12 - 14, 2009. Sam Riccitelli, ... on Tuesday, May 12, 2009 beginning at approximately 8:00 a.m. ...
... Driven by Improved Margins and Higher Sales of Select ... Companies, Inc. (NYSE: PRX ) today reported ... Par reported total revenues of $204.0 million and net ... which included a change in estimate relating to the ...
... in U.S. dollarsQUEBEC CITY, May 6 /PRNewswire-FirstCall/ - AEterna ... ("the Company"), a global biopharmaceutical company focused on endocrinology ... at and for the three months ended March 31, ... Signing of partnership with sanofi-aventis for cetrorelix ...
... Carriage Services, Inc. (NYSE: CSV ) today announced ... Merrill Lynch 2009 Health Care Conference to be held May ... Melvin Payne, Chief Executive Officer, and Terry Sanford, Chief ... 2009 at 4:00 p.m. eastern time. The live webcast ...
... from hearing loss. Hearing aids often cost thousand of dollars per pair ... money on over-the-counter hearing aids starting at under $400 and includes a ... ... -- May is Better Hearing and Speech month and according to ...
Cached Medicine News:Health News:Practicing Clinicians Exchange Forms Partnership With Restless Legs Syndrome Foundation 2Health News:Practicing Clinicians Exchange Forms Partnership With Restless Legs Syndrome Foundation 3Health News:Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference 2Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 2Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 3Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 4Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 5Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 6Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 7Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 8Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 9Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 10Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 11Health News:AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results 2Health News:AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results 3Health News:AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results 4Health News:AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results 5Health News:AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results 6Health News:AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results 7Health News:In Time for Better Hearing and Speech Month: VidaCura.com and Nexear Offers Consumers an Alternative to Traditional Costly Hearing Aids 2Health News:In Time for Better Hearing and Speech Month: VidaCura.com and Nexear Offers Consumers an Alternative to Traditional Costly Hearing Aids 3
... curtains or parting strip shields ... frame to form a free-standing, ... cleanliness to Class 10/ISO 3. ... lights, and ionizers are configured ...
Inquire...
Inquire...
Inquire...
Medicine Products: